MDT
59
2
SLG
66
4
AVGO
32
7
AVY
53
3
ESS
56
5
MCD
54
4
EXR
57
7
TXT
59
6
COST
54
4
AA
47
4
VRTX
62
10
EBAY
43
3
PWR
66
7
INTC
44
5
DG
27
-2
NRG
67
8
NVDA
55
4
LRCX
48
6
CHRW
53
3
AIV
51
4
MDT
59
2
SLG
66
4
AVGO
32
7
AVY
53
3
ESS
56
5
MCD
54
4
EXR
57
7
TXT
59
6
COST
54
4
AA
47
4
VRTX
62
10
EBAY
43
3
PWR
66
7
INTC
44
5
DG
27
-2
NRG
67
8
NVDA
55
4
LRCX
48
6
CHRW
53
3
AIV
51
4
Financhill
Back

Calian Group 10K Form

Sell
38

CGY.TO
Calian Group

Last Price:
49.79
Seasonality Move:
9.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CGY.TO News And Ratings

See the #1 stock for the next 7 days that we like better than CGY.TO

CGY.TO Financial Statistics

Sales & Book Value

Annual Sales: $658.58M
Cash Flow: $10.33M
Price / Cash Flow: 7.57
Annual Sales: $28.20
Price / Book: 1.77

Profitability

EPS (TTM): 1.41000
Net Income (TTM): $16.87M
Gross Margin: $204.21M
Return on Equity: 5.12%
Return on Assets: 2.6%

Calian Group Earnings Forecast

Key Calian Group Financial Ratios

  • The Gross Profit Margin over the past 27 years for CGY.TO is 31.01%.
  • The Selling, General & Administrative Expenses for CGY.TO have been equal to 19.25% of Gross Profit Margin.
  • The Research & Development expenses have been 1.74% of Revenue.
  • The Interest Expense is 4.74% of Operating Income.
  • The Net Earning history of CGY.TO is 2.87% of Total Revenues.
  • Per Share Earnings over the last 27 years have been positive in 16 years.

Calian Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: TSX
Industry: Commercial Services & Supplies
Sector: Industrials
Current Symbol: CGY.TO
Website: calian.com

Debt

Debt-to-Equity Ratio: 0.28
Current Ratio: 1.37
Quick Ratio: 1.01

Price-to-Earnings

Trailing P/E Ratio: 30.99
Forward P/E Ratio: 8.9

CGY.TO Technical Analysis vs Fundamental Analysis

Sell
38
Calian Group (CGY.TO) is a Sell

Is Calian Group a Buy or a Sell?

  • Calian Group stock is rated a Sell
    The current Calian Group [CGY.TO] share price is $49.89. The Score for CGY.TO is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.